12 completed, 7 unknown. 19 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 19 | Completed 12, Unknown 7 |
Follow CoronaVac: new trials by email Literature Review of CoronaVac trials Research Report on CoronaVac
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 Vaccine Ad5-nCoV-IH, Ad5-nCoV-IM, CoronaVac - COVID-19 | Phase 4 | Completed | Jiangsu Province Centers for Disease Control and Prevention | 362 | 2022-04-23 | 2025-02-21 |
| Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine Inactivated COVID-19 Vaccine - COVID-19 | Phase 4 | Unknown | Sinovac Life Sciences Co., Ltd. | 180 | 2022-04-19 | 2023-11-07 |
| Immunogenicity of an Inactivated COVID-19 Vaccine Inactivated COVID-19 Vaccine - COVID-19 | Phase 4 | Completed | Sinovac Research and Development Co., Ltd. | 395 | 2022-01-08 | 2023-09-25 |
| Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19 High-dosage SARS-CoV-2 vaccine, Medium-dosage SARS-CoV-2 vaccine - COVID-19 | Phase 4 | Unknown | Sinovac Biotech Co., Ltd | 1200 | 2021-12-17 | 2022-03-02 |
| Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study) BNT162b2, CoronaVac - COVID-19 Vaccination | Phase 4 | Completed | The University of Hong Kong | 451 | 2021-11-18 | 2026-05-15 |
| Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults Recombinant SARS-CoV-2 Ad5 vectored vaccine, Inactive SARS-CoV-2 vaccine (Vero cell) - COVID-19 | Phase 4 | Completed | Jiangsu Province Centers for Disease Control and Prevention | 300 | 2021-08-26 | 2022-08-16 |
| Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2, Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 2 of the workshop 2, Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 3 of the workshop 2 - COVID-19 | Phase 4 | Unknown | Sinovac Research and Development Co., Ltd. | 2520 | 2021-07-27 | 2023-11-07 |
| Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents Experimental Group - COVID-19 | Phase 4 | Completed | Sinovac Life Sciences Co., Ltd. | 31041 | 2021-07-24 | 2023-09-25 |
| Immunogenicity and Safety of an Inactivated COVID-19 Vaccine Inactivated COVID-19 Vaccine, 23-valent pneumococcal polysaccharide vaccine, Inactivated Hepatitis A Vaccine - COVID-19 | Phase 4 | Completed | Sinovac Research and Development Co., Ltd. | 270 | 2021-07-09 | 2022-04-14 |
| Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults SARS-CoV-2 Inactivated Vaccine, The SARS-CoV-2 Inactivated Vaccine - COVID-19 | Phase 4 | Unknown | Sinovac Research and Development Co., Ltd. | 1400 | 2021-06-19 | 2021-09-24 |
| Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults Experimental Group - COVID-19 | Phase 4 | Completed | Sinovac Research and Development Co., Ltd. | 131650 | 2021-06-05 | 2023-09-25 |
| Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector) Recombinant SARS-CoV-2 Ad5 vectored vaccine, Inactive SARS-CoV-2 vaccine (Vero cell) - COVID-19 | Phase 4 | Completed | Jiangsu Province Centers for Disease Control and Prevention | 300 | 2021-05-25 | 2022-03-31 |
| Antibody Response to COVID-19 Vaccines in Liver Disease Patients BNT162b2, CoronaVac, AZD1222 - Chronic Liver Disease | Phase 4 | Completed | Humanity & Health Medical Group Limited | 232 | 2021-05-21 | 2023-10-04 |
| Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults Inactivated SARS-CoV-2 Vaccine (Vero cell） - COVID-19 | Phase 4 | Completed | Sinovac Research and Development Co., Ltd. | 1080 | 2021-05-11 | 2022-04-13 |
| Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant Recipients Coronavac - SARS-CoV Infection, Coronavirus Infection | Phase 4 | Unknown | Hospital do Rim e Hipertensão | 3371 | 2021-03-20 | 2022-03-18 |
| Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity Adsorbed SARS-CoV-2 (inactivated) vaccine - Covid19 | Phase 4 | Unknown | Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 6233 | 2021-03-18 | 2021-07-26 |
| A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19 Adsorbed COVID-19 (inactivated) Vaccine - COVID-19 | Phase 4 | Unknown | D'Or Institute for Research and Education | 1200 | 2021-02-19 | 2021-07-09 |
| COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS CoronaVac - Rheumatic Disease, HIV Infections | Phase 4 | Completed | University of Sao Paulo General Hospital | 2196 | 2021-02-09 | 2024-03-26 |
| An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine Adsorbed COVID-19 (Inactivated) Vaccine - Covid19 | Phase 4 | Completed | Butantan Institute | 27711 | 2021-02-07 | 2024-02-15 |
COVID-19 (16) · Acquired Immunodeficiency Syndrome (1) · Arthritis, Rheumatoid (1) · Coronavirus Infections (1) · HIV Infections (1) · Lupus Erythematosus, Systemic (1) · Rheumatic Diseases (1) · Severe Acute Respiratory Syndrome (1)
Sinovac Research and Development Co., Ltd. (6) · Jiangsu Province Centers for Disease Control and Prevention (3) · Sinovac Life Sciences Co., Ltd. (2) · Butantan Institute (1) · D'Or Institute for Research and Education (1) · Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (1) · Hospital do Rim e Hipertensão (1) · Humanity & Health Medical Group Limited (1) · Sinovac Biotech Co., Ltd (1) · The University of Hong Kong (1) · University of Sao Paulo General Hospital (1)
China (12) · Brazil (5) · Hong Kong (2)
Dongjuan Zhang (2) · Fubing Wang (2) · Hongxing Pan, Master (2) · Jing-Xin Li, PhD (2) · Li Zhang, Master (2) · Qing Wang (2) · Qiuyun Deng (2) · Ruizhi Zhang (2) · Shicheng Guo (2) · Xiaoqiang Liu, Doctor (2) · Xiaoshu Zhang (2) · Xing Fang (2) · Yeqing Tong (2) · Zhaodan Sun (2) · Benjamin J Cowling, PhD (1)
PMID 36658045, PMID 34292214, PMID 34331051, PMID 34664616, PMID 34806342, PMID 34882589, PMID 34894235, PMID 34901885, PMID 34954325, PMID 34974453, PMID 35087233, PMID 35135832, PMID 35193873, PMID 35277389, PMID 35306594, PMID 35639644, PMID 35844042, PMID 36150668, PMID 36192386, PMID 36441137, PMID 36529052, PMID 36870351, PMID 36898400, PMID 37202147, PMID 37291679, PMID 37325662, PMID 37360864, PMID 37549680, PMID 39191745, PMID 41714650, PMID 42261247, PMID 42329996, PMID 42464341